期刊文献+

DV2 NGC株感染BALB/C小鼠后IL-4、IFN-γ产生动态的研究 被引量:2

The dynamic observation of the levels of IL-4 and IFN-γ in the BALB/C mice infected with DV2 NGC strain
下载PDF
导出
摘要 目的 :观察 2型登革病毒NGC株感染BALB C小鼠后其IL 4、IFN γ产生动态 ,研究登革病毒感染的免疫机制。方法 :用不同含量的DV2NGC株经皮下多点注射 ,间接ELISA法测定感染后不同时间各组小鼠血浆IL 4、IFN γ含量。结果 :DV2NGC株感染小鼠产生IL 4和IFN γ动态不同。初次感染早期 ,IL 4水平明显升高 ,而IFN γ处于较低水平 ;再次感染后第 1天 ,IL 4水平达最高峰 ( 4 2 94 6 6 8± 349 0 38pg ml) ,IFN γ则于第 4天和第 11天达较高水平 ,两者的产生彼消此长 ,且产生动态与感染病毒量有关。结论 :DV2NGC株感染早期 ,体液免疫和细胞免疫相互影响 ,体液免疫占主导作用 ,为Th2应答优势。但在登革热感染后期 ,细胞免疫一定程度抑制Th2应答 。 Objective:BALB/C mice model infected with DV2 NGC strain was evaluated and dynamic patterns of cytokines were investigated.Methods:The dynamic changes of cytokines were observed in the infected BALB/C mice model by indirect ELISA was observed.Results:The dynamic levels of IL-4、IFN-γ in the plasma of BALB/C mice after primary and secondary infected DV2 NGC strain were different.The results showed that the levels of IL-4 were significantly increasing in the early primary infected BALB/C mice while that of IFN-γ were lower;In secondary infection ,IL-4 reached a peak on the first day( 4294 668 ± 349 038 pg/ml) and then the levels of IFN-γ were higher on the forth and eleventh day.The concentrations of the cytokines produced infectious animals had closely relationship with the doses of DV2.Conclusion:Infection eliciting a dominant humonral immune response induced a high expression of Th2-related cytokines,whereas those show some appearance of Th1 cytokines.Th1 response,as described late for the disease infected with DV2 NGC strain,played a role while it inhibited Th2 response to some extend.Thus,it was responsible to recovery.Th cell and the cytokines were critic to the DV infective diseases.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2004年第5期303-305,310,共4页 Chinese Journal of Immunology
基金 国家科学基金资助(资助号 :3 9960 0 0 1) 贵州省优秀科技教育人才省长基金资助 (2 0 0 1)
关键词 登革病毒 TH1/TH2 IL-4 IFN-γ Dengue type 2 virus Th1/Th2 IL-4 IFN-γ
  • 相关文献

参考文献4

  • 1Tom Clarker.4 related articles,links dengue virus:break-bone fever[J].Nature,2002;416(6882):672-674.
  • 2Libraty D H,Pichyangkul S,Ajariyakhajorn C et al.Human dendritic cells are activated by dengue virus infection:enhancement by gamma interferon and implications for disease pathogenesis[J].J Virol,2001;75(8):3501-3508.
  • 3Chaturvei U C,Agarwal R,Elbishbishi E A et al.Cytokine cascade in dengue hemorrhagic fever:implications for pathogensis[J].FEMS Immunol Med Microbiol,2000;28(3):183-188.
  • 4King C A,Marshall J S,Alshurafa H et al.Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line[J].J Virol,2000;74(15):7146-7150.

同被引文献24

  • 1胡静,何小军,冯永东,杨长永,韩中博,龚建平.正常人外周血淋巴细胞凋亡受体的表达与细胞凋亡的关系[J].中国实验血液学杂志,2007,15(3):533-536. 被引量:5
  • 2Izuhara K. The role of interleukin-4 and interleukin-13 in the nonimmunologic aspects of asthma pathogenesis. Clin Chem Lab Med, 2003 ;41 (7) :860 - 864.
  • 3Obregon C, Rothen-Rutishauser B, Gerber P, et al. Active uptake of dendritic cell-derived exovesicles by epithelial cells induces the release of inflammatory mediators through a TNF-alpha-mediated pathway. Am J Pathol, 2009;175(2) :696 -705.
  • 4Verma YK, Gangenahalli GU, Singh VK. Cell death regulation by B-cell lymphoma protein. Apoptosis, 2006 ; 11 (4) :459 - 471.
  • 5Antony PA, Restifo NP. CD4^+ CD25^+ T regulatory cells, immu- notherapy of cancer, and interleukin-2. J Immunother, 2005;28 (2) :120 -128.
  • 6Mohan S, Mohanasenthil, Paul SF. Interleukin-4-receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population. Asian Pac J Cancer Prey. 2009; 10(2) :295 - 298.
  • 7Boyman O, Surh CD, Sprent J. Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease. Expert Opin Biol Ther, 2006 ;6 (12) :1323 -1331.
  • 8Neis MM, Peters B, Dreuw A, et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol, 2006 ; 118 (4) :930 - 937.
  • 9Sangro B, Melero I, Qian C, et al. Gene therapy of cancer based on interleukin 12. Curr Gene Ther, 2005 ;5 (6) : 573 - 581.
  • 10Rook All, Kuzel TM, Olsen EA. Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2. Hematol Oncol Clin North Am, 2003 ;17(6) :1435 -1448.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部